Jacobs School of Medicine and Biomedical Sciences

A powerful partnership that brought University at Buffalo faculty and community leaders together to fight against health disparities has allowed the community to blunt the effect of the coronavirus pandemic on Buffalo’s most vulnerable citizens.

Jun Xia, PhD, has received a four-year, $1.4 million grant from the National Institutes of Health (NIH) to develop a new, portable breast-imaging system that has the potential to better identify breast cancer.

Oscar G. Gomez, MD, PhD, associate professor of pediatrics and chief of its Division of Infectious Diseases, has completed the genomic analysis of a specific strain of Shiga-toxin E. coli (STEC) that can cause severe disease outbreaks and is increasingly common. 

The impact of the global health pandemic on the Jacobs School of Medicine and Biomedical Sciences is far-reaching in terms of its medical education program, residency and fellowship training programs and its research endeavors.

The Jacobs School of Medicine and Biomedical Sciences celebrated scientific achievements and outstanding service and teaching contributions during the 2020 Faculty and Staff Recognition Awards event.

CLIMB, an innovative and comprehensive diversity program at the University at Buffalo that provides intensive mentoring experiences for biosciences students from undergraduate through postdoctoral levels, has received an award from INSIGHT into Diversity magazine.

Jennifer A. Surtees, PhD, associate professor of biochemistry, is leading an effort to track the genomics of COVID-19 in Western New York.

The findings from a recent study by a Jacobs School of Medicine and Biomedical Sciences researcher and others could prove to be a game-changer for men with Type 2 diabetes and the syndrome of hypogonadism.

Research led by Zhen Yan, PhD, SUNY Distinguished Professor of physiology and biophysics, describes a sensitive and reliable new protocol for assessing social deficits in animal models of autism and certain psychiatric conditions.

A startup company with roots at the University at Buffalo is setting a new course that could eventually help organizations around the world better navigate return-to-work plans amid the COVID-19 pandemic.

Along with international co-authors, Praveen K. Chandrasekharan, MD, has outlined the best approaches for handling the delivery of newborns in cases where the mother tests positive for COVID-19 or is suspected of having the virus.

New research reveals that certain studies — clinical trials on drugs that appeared not to benefit patients with Alzheimer’s disease — should now be reanalyzed in light of recent discoveries about a gene called CHRFAM7A.